HSTO News and Press, Histogen Inc. From 08/11/22

Histogen press release ( NASDAQ: HSTO ): Q2 GAAP EPS of -$1.55. Cash and cash equivalents as of June 30, 2022 were $12.6M which excludes gross proceeds of approximately $5M from the private placement financing closed in July 2022. For further details see: Histoge...

Closed $5M Financing in July Regained Compliance with Nasdaq Minimum Bid Price Requirement SAN DIEGO, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics for orthopedic indi...

Major earnings expected after the bell on Thursday include: Illumina ( ILMN ) Rivian Automotive ( RIVN ) Sandstorm Gold Ltd. ( SAND ) Vermilion Energy ( VET ) Wheaton Precious Metals Corp. ( WPM ) For further details see: Notable earnings ...

Hyzon Motors ( HYZN ) -36% after disclosing operational inefficiencies, financial issues . Helius Medical Technologies ( HSDT ) -30% . Quoin Pharmaceuticals ( QNRX ) -23% . Chembio Diagnostics ( CEMI ) -18% on Q2 earnings release . ...

InVivo Therapeutics Holdings ( NVIV ) +106% . GreenLight Biosciences ( GRNA ) +94% . NanoViricides ( NNVC ) +48% stock skyrockets 50% on start of drug development program for monkeypox. Exicure ( XCUR ) +39% . Global Blood Therapeuti...

SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases, today announc...

SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing both restorative therapeutics and pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases, announced tod...

Humanigen HGEN -68% as trial for COVID-19 therapy fails . Atara Biotherapeutics ATRA -46% on interim analysis of phase 2 study for multiple sclerosis candidate. TherapeuticsMD TXMD -41% as merger agreement ends . Helius Medical Technologies ( HSDT...

A clinical-stage therapeutics company, Histogen ( NASDAQ: HSTO ) has entered into a securities purchase agreement with a single healthcare-focused institutional investor to issue 1.77M shares of common stock, Series A warrants to purchase additional 1.77M and Series B warrants...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Bed Bath & Beyond (NASDAQ: BBBY ) stock is in the news today after an incredibly bearish analyst said the retailer’s shares will fall to $1 a piece . Loop Capital analyst Antho...